Symbol
|
RMXLTQ | LXSWLK | KQKRCH | AOIBKB | UVSLTQ | KRPRCH | Z05RUZ | KMQZDU | KMUUDU | RMAI6V | ATLBKB | CPWCBL | KNJPDU | KNIWDU | KNIYDU | KNKUDU | KNOIDU | KNNMDU | CROCBL | AAKRSQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Callable Multi Barrier Reverse Convertible | LUKB Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible |
Sous-jacent
|
Compagnie Financière Richemont SA / Givaudan / Lonza Group N / Nestlé S.A. | Logitech International SA / Lonza Group N / Sika AG / Straumann Hldg. AG | Lonza Group N / Novartis Sandoz Basket / Roche AG | Alcon / Lonza Group N / Novartis Sandoz Basket / Roche AG | BASF SE / Bayer AG / Lonza Group N / Sika AG | LafargeHolcim Ltd. / Lonza Group N / Stadler Rail AG | Lonza Group N / Sonova Hldg. AG / Straumann Hldg. AG | Idorsia AG / Lonza Group N / Sonova Hldg. AG | Alcon / Lonza Group N / Roche AG | ABB N / Givaudan / Lonza Group N / Sika AG | Lonza Group N / Novartis Sandoz Basket / Roche AG | BASF SE / Bayer AG / Lonza Group N / Sika AG | Julius Baer Group / Lonza Group N / Swatch Group I | Geberit AG / Lonza Group N / Sika AG | ABB N / Givaudan / Lonza Group N / Swatch Group I | Clariant / Lonza / Sika | BASF SE / Bayer AG / Clariant AG / Lonza Group N | Lonza Group N / Novartis Sandoz Basket / Roche AG | BASF SE / Bayer AG / Givaudan / Lonza Group N | Ems-Chemie Hldg. AG / Lonza Group N / Novartis Sandoz Basket / Roche AG / Sika AG |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
26.08.2024 | 01.10.2024 | 12.08.2024 | 29.07.2024 | 19.08.2024 | 26.08.2024 | 03.03.2025 | 30.09.2024 | 21.10.2024 | 10.11.2025 | 16.12.2024 | 16.12.2024 | 18.07.2024 | 18.07.2024 | 18.07.2024 | 27.01.2025 | 15.08.2024 | 15.08.2024 | 13.08.2024 | 20.08.2024 |
Demande | 69,03 | 62,42 | 101,13 | 101,50 | 51,83 | 87,75 | 99,98 | 17,060 | 100,20 | 103,30 | 100,82 | 56,49 | 99,15 | 99,10 | 99,15 | 101,10 | 42,750 | 99,50 | 49,280 | 95,13 |
Offre | 66,10 | 62,89 | 101,94 | 102,32 | - | - | 100,48 | 18,060 | 101,20 | 104,30 | 101,63 | - | 100,20 | 100,10 | 100,10 | 102,10 | 43,750 | - | - | - |